These animals exhibit a dampened response to GLP-1-induced weight loss relative to DIO C57B6/J mice, which is reminiscent of the reduced weight lowering efficacy of GLP-1 drugs seen in patients with obesity and type 2 diabetes (T2D) compared to obesity alone. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.